America’s employers must stop acting helpless in the face of health care industry profiteering, Chris Deacon says.

Read the 5 key takeaways from STAT's series "Out of Pocket, Out of Reach," an examination of workplace health insurance.

In the past, the possibility of endemic Ebola was unthinkable. This time is different, write Ivan Buendia Gayton and Eric D.

Gen Z physicians are on a collision course with institutions still built around older assumptions,” writes Frantz M. Berthaud ...

Vertex Pharmaceuticals will spend $10 billion to acquire Crinetics Pharmaceuticals and its drug for a rare endocrine disorder ...

Join us at 1 p.m. EST July 22 to learn more about his series on the soaring costs of employer-based health insurance.

States across the country saw steep drops in the number of people covered by the Affordable Care Act over the past year, ...

A new secret-shopper study found that GLP-1 prescriptions from telehealth sites aren't often backed by appropriate clinical ...

Call AI in biotech hype at your peril. There are real reasons that pharmaceutical companies are embracing this technology ...

Rose covers disability and mental health, and she helps write STAT’s daily Morning Rounds newsletter. Confidential tips can be sent to Rose on Signal at rosebroderick.11. Annalisa (Nalis) Merelli is ...

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — Clinical trial policy ...

The newly cleared device is based around an app that helps a patient manage their diabetes using a treatment plan defined by ...